Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATX-898 in Advanced Solid Tumors
NCT07767474Phase 2Recruiting
- Sponsor
- Antares Therapeutics
- Start
- Aug 2026
- Primary completion
- Oct 2029
- Countries
- 2
01
Overview
A Phase 2 trial of ATX-898 in solid tumor, ovarian cancer, gynecologic cancer, breast cancer, sponsored by Antares Therapeutics. Started Aug 2026; status: recruiting.
02
Drugs
ATX-898
03
Conditions
solid tumorovarian cancergynecologic cancerbreast cancer
Beyond the preview
Go deeper on NCT07767474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07767474.